Back to Journals » Journal of Asthma and Allergy » Volume 11

Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers

Authors Jimenez-Rodriguez TW, Garcia-Neuer M, Alenazy LA, Castells M

Received 9 December 2017

Accepted for publication 21 February 2018

Published 20 June 2018 Volume 2018:11 Pages 121—142

DOI https://doi.org/10.2147/JAA.S159411

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Amrita Dosanjh


Teodorikez Wilfox Jimenez-Rodriguez,1–3 Marlene Garcia-Neuer,1 Leila A Alenazy,1,4 Mariana Castells1

1Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; 2Allergy Section, Alicante General University Hospital, Alicante, Spain; 3PhD Program in Public Health, Medical and Surgical Sciences, Miguel Hernandez University, Alicante, Spain; 4Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Abstract: Anaphylaxis is the most serious of all allergic reactions and can be fatal. The diagnosis is frequently delayed, and misdiagnosis often occurs with asthma or urticaria. Biomarkers such as tryptase are not routinely checked, and appropriate treatment with epinephrine is not administered in a majority of cases, increasing the risk of poor outcomes. The objective of this review is to provide a better understanding of the pathophysiology of anaphylaxis with a description of phenotypes, endotypes, and biomarkers available in both the clinical and research settings. Expanding knowledge with regard to the presentation, causes, and triggers for anaphylaxis among health care providers will improve its diagnosis and management, increase patient safety, and decrease morbidity and mortality.

Keywords: anaphylaxis, hypersensitivity reactions, tryptase, autoimmune progesterone dermatitis, epinephrine, precision medicine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]